ScienceAlert on MSN2d
New Protein Discovery Could Rival Ozempic With Fewer Side Effects
Scientists have discovered a naturally occurring molecule that aids appetite control and weight loss so well, it may compete ...
News-Medical.Net on MSN4d
GLP-1 drugs may cut risk of leukemia and lymphoma in type 2 diabetes patients
Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...
News-Medical.Net on MSN7d
Naturally occurring molecule suppresses appetite and promotes weight loss
A naturally occurring molecule identified by Stanford Medicine researchers appears similar to semaglutide - also known as Ozempic - in suppressing appetite and reducing body weight.
Morningstar21d
Immunic's Oral IMU-856 Demonstrated Dose-Dependent Increase of GLP-1 in Celiac Disease Patients and Corresponding Effects in Preclinical Testing
an orally available and systemically acting small molecule modulator that targets SIRT6 (Sirtuin 6), demonstrated a dose-dependent increase of endogenous glucagon-like peptide-1 (GLP-1 ...
Pharmabiz13d
Biocon introduces glucagon-like peptide-1, Liraglutide in United Kingdom
Liraglutide in United Kingdom: Our Bureau, Bengaluru Friday, February 28, 2025, 15:30 Hrs [IST] Biocon Limited, an innovation-led global ...